BTN3A1 and pancreatic ductal adenocarcinoma: The expression of BTN3A1 was positively correlated with the overall survival rate of patients with bladder cancer 27, but negatively correlated with the overall survival rate of patients with pancreatic ductal adenocarcinoma 28.